Israel Englander’s Puma Biotechnology PBYI Stock Holding History

Israel Englander’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-128,300	Closed	-$11.2M	–	3772
2017 Q2	$11.2M	Buy	128,300 +39,300	+44%	+$2.2M	0.02%	988
2017 Q1	$3.31M	Buy	+89,000	New	+$3.25M	0.01%	1708
2016 Q4	–	Sell	-17,500	Closed	-$1.17M	–	3622
2016 Q3	$1.17M	Sell	17,500 -107,500	-86%	-$5.44M	﹤0.01%	2200
2016 Q2	$3.72M	Sell	125,000 -35,000	-22%	-$1.09M	0.01%	1439
2016 Q1	$4.7M	Sell	160,000 -1,600	-1%	-$72.3K	0.01%	1285
2015 Q4	$12.7M	Buy	+161,600	New	+$12.7M	0.03%	802
2015 Q2	–	Sell	-20,000	Closed	-$4.72M	–	3704
2015 Q1	$4.72M	Buy	20,000 +12,400	+163%	+$2.65M	0.01%	1439
2014 Q4	$1.44M	Buy	+7,600	New	+$1.69M	﹤0.01%	2233

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's PBYI Position: Q2 2026 in Review

Israel Englander reduced its Puma Biotechnology (PBYI) stake by 59% in Q2 2026, selling an estimated $6.41M and leaving 602,240 shares worth $4.88M. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

Israel Englander first reported a position in PBYI in Q2 2013 and has held it in 51 quarters since. The position peaked at $127M in Q2 2017. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Israel Englander held 602,240 shares of Puma Biotechnology worth $4.88M as of Q2 2026.
Israel Englander sold 875,279 Puma Biotechnology shares in Q2 2026, an estimated $6.41M.
Puma Biotechnology made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3017 holding.
Israel Englander first reported a position in Puma Biotechnology in Q2 2013 and has held it in 51 quarters since.
Israel Englander's Puma Biotechnology position peaked at $127M in Q2 2017.
160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.